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Glaucoma is a major cause of blindness in the world. To date, common genetic variants associated with glau-
coma only explain a small proportion of its heritability. We performed a genome-wide association study of
intra-ocular pressure (IOP), an underlying endophenotype for glaucoma. The discovery phase of the study
wascarriedout in theTwinsUKcohort (N 5 2774)analyzingassociationbetween IOPandsinglenucleotidepoly-
morphisms (SNPs) imputed to HapMap2. The results were validated in 12 independent replication cohorts of
European ancestry (combined N 5 22 789) that were a part of the International Glaucoma Genetics
Consortium. Expression quantitative trait locus (eQTL) analyses of the significantly associated SNPswere per-
formed using data from the Multiple Tissue Human Expression Resource (MuTHER) Study. In the TwinsUK
cohort, IOP was significantly associated with a number of SNPs at 9q33.3 (P 5 3.48 3 1028 for rs2286885, the
most significantly associated SNP at this locus), within the genomic sequence of the FAM125B gene.
Independent replication inacompositepanelof12cohorts revealedconsistentdirectionofeffectandsignificant
association (P 5 0.003, for fixed-effectmeta-analysis). Suggestive evidence for aneQTLeffect of rs2286885was
observed for one of the probes targeting the coding region of the FAM125B gene. This gene codes for a compo-
nent of a membrane complex involved in vesicular trafficking process, a function similar to that of the Caveolin
genes (CAV1 andCAV2) which have previously been associatedwith primary open-angle glaucoma. This study
suggests a novel association betweenSNPs inFAM125B and IOP in the TwinsUKcohort, though further studies
to elucidate the functional role of this gene in glaucoma are necessary.
INTRODUCTION
Glaucoma represents a group of optic neuropathies character-
ized by a typical pattern of optic nerve damage resulting from
loss of retinal ganglion cells and axons. Glaucoma accounts
for a significant portion of the global burden of visual impair-
ment, being the third leading cause of visual impairment and
the second leading cause of blindness in the world (1).
Raised intra-ocular pressure (IOP) is a major modifiable risk
factor for glaucoma (2,3) and treatment directed at lowering
IOP remains the mainstay of current glaucoma treatment (3,4).
IOP is a heritable trait, with heritability estimates ranging from
0.35 to0.74 indifferent studies (5–7). Investigating genetic vari-
ation influencing IOP might help better understand IOP regula-
tion and its role in glaucoma pathophysiology. So far, in the
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case of glaucoma, case–control studies and quantitative trait-
based approaches have jointly identified a number of genes
that influence the risk of developing clinical glaucoma as well
as cause incremental changes in population-wide risk of the
underlying quantitative traits. These include the association of
TMCO1 with open-angle glaucoma (OAG) (8) and IOP (9),
and the association of CDKN2B with OAG (8,10) and vertical
cup-to-disc ratio (11). This convergence of evidence between
variants associated with glaucoma and those associated with
‘healthy’ variation in quantitative traits underlying the disease,
justifies the use of quantitative traits (endophenotypes) to
dissect the genetic basis of glaucoma.
Here, we describe a genome-wide association study (GWAS)
investigating the healthy variation of IOP in general populations
of European ancestry and report findings about genetic variants
that we found consistently associated with IOP in the participat-
ing cohorts.
RESULTS
Association testing in the TwinsUK cohort was performed for
1.87millionSNPs that passedourquality control (QC) criteria.
Both the genomic inflation factor (1.036) and the quantile plot
(Supplementary material, Fig. S1) of the results indicate no sig-
nificant inflation of test statistics due to population stratification.
The regionmost significantly associatedwith IOPwas9q33.3,
where three SNPs crossed the conventional threshold for
genome-wide significance (Figs 1 and 2). In no other region
SNPs crossed this significance threshold. Of the two previously
reported IOP loci by van Koolwijk et al. (9), in which TwinsUK
was one of the participating studies, rs11656696 on the GAS7
locus showed statistically significant replication (P ¼ 1.36 ×
1022), although not at a GWAS level; while the association for
rs7555523 on the TMCO1 locus was not statistically significant
(P ¼ 2.4 × 1021) (9).
The most significantly associated SNP at 9q33.3 was
rs2286885 (P ¼ 3.48 × 1028). Each copy of the A allele of
this SNP increased IOP on average by 0.56 mmHg (95% CI:
0.36–0.75 mmHg). Two other SNPs at this locus that were sig-
nificantly associated with IOP (rs2286886 and rs10819169)
were in perfect linkage disequilibrium (LD) with rs2286885.
This association remained the same (b ¼ 0.56, SE ¼ 0.103,
P ¼ 6.5 × 1028 for rs2286885) after inclusionof thegenotyping
batch as a covariate in the analysis. For rs2286885, adjustment
for central corneal thickness (CCT) improved the evidence for
its association (b on adjustment for CCT ¼ 0.59 mmHg; P ¼
1.16 × 1029); adjustment for SBP, on the other hand, decreased
the significance of association (b on adjustment for SBP ¼
0.50 mmHg; P ¼ 6.46 × 1027). The direction and magnitude
of effect for rs2286885 remained unchanged on stratifying by
sex and after selecting one twin from each pair.
The rs2286885 polymorphism is located within intron 8 of
the FAM125B gene (Homo sapiens family with sequence
Figure 2. Regional association plot of the region 9q33.3 in the Twins UK cohort.
Figure1.Results of theGWAS in theTwinsUKcohort (The upper line in the plot
demarcates SNPs that are genome-wide significant (P , 5 × 1028) and the
lower line demarcates SNPs that show suggestive significance (P , 5 × 1026)).
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similarity 125, member B). FAM125B codes for two different
isoforms (isoform 1 and isoform 2) that contain 10 and 6
exons, respectively. The protein encoded by this gene (multive-
sicular body subunit 12B, also known as MVB12B) is a compo-
nent of the ESCRT-I (endosomal sorting complex required for
transport I) complex, a heterotetramer, which mediates the
sorting of ubiquitinated cargo proteins from the plasma mem-
brane to the endosomal vesicle.
We attempted to replicate the most significantly associated
SNP at 9q33.3, rs2286885, in European cohorts participating
in the International Glaucoma Genetics Consortium (IGGC).
With the exception of one cohort, the direction of effect for
rs2286885 was consistent with the one observed in the
TwinsUK in all the other replication cohorts (Table 1). In a com-
bined fixed-effect inverse variance meta-analysis of all the rep-
lication cohorts, rs2286885 was associated with IOP (P ¼
0.003) (Fig. 3). The magnitude of the effect was noticeably
less in the replication panel, with each copy of the risk allele
(A) of rs2286885 increasing IOP by 0.09 mmHg (95% CI:
0.03–0.14 mmHg). A joint meta-analysis of the discovery and
replication samples thus reduced the strength of association
(P ¼ 5.67 × 1026), with each copy of the risk allele (A) of
rs2286885 increasing IOP by 0.12 mmHg (95% CI: 0.07–
0.18 mmHg).
We checked for associations between rs2286885 and the
three probes of the HumanHT-12 array covering FAM125B
coding regions. There was some evidence for an eQTL associ-
ation, with the best observed SNP-expression association
being between rs2286885 (which was the top IOP-associated
SNP at the locus) and the probe (ILMN_1652525) targeting
the isoform 1 ofFAM125B in fat tissue (P ¼ 0.02). The observed
eQTL association however does not survive multiple testing cor-
rections for number of probes and number of tissues tested.
DISCUSSION
Here we report a novel association between variants located on
the long arm of chromosome 9 and IOP levels. Our conclusions
were based on GWAS results of one population of European
descent, and replication of the variants in a compound panel of
12 independent populations of the same ancestry. The SNPs at
9q33.3 associated with IOP are within the LD block that contains
the gene FAM125B. The protein product of FAM125B forms a
component of ESCRT-I, a highly conserved complex (12), that
is involved in vesicular trafficking process (also known as trans-
cytosis). It is thought that vesicular transport/cell membrane re-
modelling pathways in the endothelial cells of the eye regulate
IOP through active modulation of the formation of giant
vacuoles and endothelial pores (13), which controls the drainage
rather than the production of aqueous humour in the eye. Further
support for the importance of this metabolic pathway in the de-
termination of IOP is the recent discovery of the formation of
intracellular vesicles in cultured human trabeculocytes in re-
sponse to treatment with latanoprost, a drug which is a well
known first line drop treatment to lower IOP (14). Incidentally,
Table 1. Results for rs2286885 in the discovery and replication studies
Cohort Number of subjectsa Frequencyb bb SE P-value
TwinsUK (discovery study) 2772 0.55 0.56 0.101 3.48 × 1028
BATS 1152 0.53 0.147 0.13 0.2602
BMES 1667 0.55 0.0384 0.099 0.6994
ERF 2589 0.57 0.064 0.089 0.476
Framingham 2455 0.54 0.090 0.091 0.327
GHS1 2727 0.56 0.136 0.078 0.081
GHS2 1130 0.55 20.020 0.113 0.858
ORCADES 474 0.54 0.358 0.184 0.051
RSIII 2034 0.57 0.057 0.092 0.537
RSII 2116 0.56 0.066 0.094 0.483
RSI 5782 0.57 0.101 0.062 0.106
Southampton 166 0.55 0.042 0.492 0.932
TEST 663 0.53 0.010 0.194 0.960
BATS, Brisbane Adolescent Twin Study; BMES, Blue Mountains Eye Study; ERF, Erasmus Rucphen Family Study; GHS, Guttenberg Health Study; ORCADES,
Orkney Complex Disease Study; RS, Rotterdam Study; TEST, Tasmanian Eye Study of Twins; SE, dtandard error.
aNumber of subjects refers to those with genotype information for rs2286885.
bFrequency and beta refer to the frequency and the effect size respectively for the A allele of rs2286885.
Figure3.Forest plot for rs2286885 for the replication cohorts. ES, effect size; CI,
confidence intervals; BATS, Brisbane Adolescent Twin Study; BMES, Blue
Mountains Eye Study; ERF, Erasmus Rucphen Family Study; GHS, Gutenberg
Health Study; ORCADES, Orkney Complex Disease Study; RS, Rotterdam
Study; TEST, Tasmanian Eye Study of Twins.
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a recent study has identified association for IOP with variants in
another gene (ICA1) that is also involved in vesicular transporta-
tion/cell membrane remodelling (15). In the absence of a case–
control panel to test the role of the associated SNPs inFAM125B
in glaucoma, we hypothesize that FAM125B could potentially
mediate susceptibility to glaucoma through the vesicular trans-
portation/cell membrane remodelling pathways, which have
previously been implicated in glaucoma through the reported as-
sociation of the CAV1–CAV2 genes (16).
FAM125B mRNA is highly expressed in the human retina
(http://biogps.org/). The result of our eQTL analysis was con-
strained by tissue availability. We observed only modest eQTL
association for rs2286885 and FAM125B in one of the three
non-ocular tissues we studied; however the possibility of exist-
ence of such an effect cannot be ruled out as gene expression is
known to be a tissue-specific phenomenon (17).
Our results are important for a number of reasons. First they are
illustrative of the fact that the path towards elucidating the genetic
architecture of the complex traits such as IOP is still long and that
there is still place forGWASto identifygenesandgeneticallycon-
trolled mechanisms that had previously eluded us. The effect size
of the variants identified inFAM125B is small, as is the portion of
the phenotypic variance that can be attributed to them. The find-
ings are consistent with GWAS findings for most complex dis-
eases to date (18), which has changed the way we look at
complex disease genetics from an oligogenic to a plurigenic
model,with hundreds and potentially thousands of individual var-
iants contributing to phenotypic variation (19).
Second, our results offer an interesting insight on the phenom-
enon of ‘winner’s curse’. Selection of SNP associations, robust
to conservative Bonferroni correction, to be taken forward to
subsequent replication stages, often leads to a bias towards
selecting SNPs whose effect sizes in the discovery cohort are
over-estimated, albeit truly positive (20). This way of selecting
replication SNPs encourages a ‘winner’s curse’ phenomenon.
This is neither a new nor a harmful phenomenon; it has been
well documented for some of the major confirmed results for a
variety of traits in the GWAS era (21). Thus, in the discovery
phase of our study, the estimated effect size of the associated var-
iants at 9q33.3 appears to be over-estimated; while the effect
sizes observed in the replication cohorts might reflect the true
effect of the variants.
Third, these results show the wide range of possibilities that
can explain the connection between DNA sequence variations
with phenotypic expression. The associated variants in
FAM125B were located within the intron 8 of the gene. The
exons that flank this intron code for the isoform 1 of the
protein product; on the other hand, the flanking exons are
spliced out of the pre-mRNA when coding for the isoform
2. Moreover, our eQTL results showed association with only
the isoform 1 of the gene, but not with the isoform 2. Our
results could suggest a possible link between alternative spli-
cing/ isoform expression at this locus and IOP regulation, but
tissue specificity is likely to remain a difficult problem to
tacklewhenstudyingexpressionofgenes involved inocular phe-
notypes.
Fourth, it is known that CCT influences IOP readings (22,23),
andwithCCTbeing ahighlyheritable trait (estimates range from
0.72 to 0.95) (5,6,24), there exists the possibility of CCT con-
founding genetic associations for IOP. Adjustment for CCT in
our analysis improved the strength of association for SNPs at
9q33.3 locus, thus highlighting the fact that the locus regulates
IOP rather than CCT. This also supports the notion that pheno-
type refinement for complex traits offers an effective strategy
to improve the power to detect genetic variants underlying them.
A potential drawback of our study is that the discovery phase
was conducted in a cohort with specific demographic features—
aUK-based, predominantly female population. This might limit
generalization, so replication of our findings in other cohorts
with differing demographic structures is important. Three out
of the four Asian cohorts of IGGC did not replicate the direction
of effect for rs2286885 (Supplementary Material, Table S2), a
finding that could reflect differences in LD pattern at this locus
between European and Asian populations, justifying our deci-
sion to include only the European cohorts in the replication.
We further investigated the population diversity of the asso-
ciated variants at 9q33.3 in European (HapMap-CEU) and
Asian (HapMap-HCB and HapMap-JPT) population panels of
HapMap. A significant difference in the allele frequency
pattern of rs2286885 was noted between European and Asian
populations—the frequency of the risk allele (A) of this SNP
was about 55% in the European population, while it was 25
and 28% in the two Asian populations. This is indicative of dif-
fering haplotypic frequencies, and thus differences in the pat-
terns of LD at this locus between European and Asians
populations. Such variations in LD patterns between popula-
tions, if not accounted for, can confound the ability to detect
associationswhenanalyzingethnicallyheterogenouspopulation
panels (25).
Although GWAS evidence presented here suggests associ-
ation between FAM125B and IOP, short of any direct biological
evidence, association results remain probabilistic that still have
the potential of a type I error. Results from individual GWAS
may be opening small windows into the genetic architecture of
IOP and, by extension, glaucoma; however, functional charac-
terization of the gene function will be necessary to fulfil the po-
tential translational benefits of such studies.
MATERIALS ANDMETHODS
Weanalysed2774participants (95%female and all ofCaucasian
ancestry) within the TwinsUK adult twin registry based at
St. Thomas’ Hospital in London (26) for whom both genotype
and IOP information was available (Supplementary Material,
Table S1). Of the 2774 subjects, 681 were monozygotic twin
pairs, 627were dizygotic twin pairs and 158were unrelated indi-
viduals. Twins largely volunteered unaware of the eye studies
interests at the time of enrolment and gave fully informed
consent under a protocol reviewed by the St. Thomas’ Hospital
Local Research Ethics Committee. Exclusion criteria included
any form of glaucoma surgery such as trabeculectomy or laser
surgery that could alter IOP.
Wemeasured IOPwith a non-contact air-puff tonometer. The
Ocular Response Analyser (ORA; Reichertw, Buffalo, NY,
USA) ejects an air impulse in order to flatten the cornea, which
is detected by an electro-optical collimation system. The mean
IOP was calculated from four readings (two from each eye) for
each participant. IOP for subjects receiving IOP-lowering med-
ications (26 out of 2774) was imputed by increasing the
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measured value by 30%, based on efficacy data from commonly
prescribed therapies (27). As CCT and systolic blood pressure
(SBP) are known to influence IOP measurements (23), they
were included as covariates in the analysis. CCT was measured
using an ultrasound pachymetry device provided with the ORA
instrument. Three SBP measurements were made for each
subject using automated calibrated instrument, of which the
average of the second and the third readings were considered
for the analysis.
Subjects were genotyped in two different batches of approxi-
mately the same size, using two genotyping platforms from Illu-
mina: 300 K Duo and HumanHap610-Quad arrays. Whole
genome imputation of the genotypes was performed using
HapMap2 (www.hapmap.org) haplotypes.
Stringent QC measures were implemented, including
minimum genotyping success rate (.95%), Hardy–Weinberg
equilibrium (P . 1026),minimumMAF(.1%) and imputation
quality score (.0.7). Subjects of non-Caucasian ancestry were
excluded from the analysis.
A linear regressionmodel, adjusted for age and sex, was fitted
to test for association between genome-wide SNPs as independ-
ent and IOP as the dependent variable. An additive model of
effect for the risk allele of an SNPwas implemented. Additional
analyses were performedwith CCT and SBP as covariates in the
analysis. A score test statistic as implemented inMERLIN (28),
that takes into account the pedigree structure and the zygosity of
the twins, was used to adjust for the non-independence of the
observations.
Loci conventionally considered genome-wide significant
(P , 5 × 1028) in the discovery cohort were taken forward
and meta-analysed using the summary statistics data obtained
from 12 independent cohorts of European ancestry that were
a part of the IGGC. Individual cohorts performed the replication
association analyses for rs2286885 based on a protocol decided
by the consortium in order to ensure consistency in the analyses.
The replication cohorts had a combined sample size of 22 789;
complete descriptions of the study populations, phenotyping
and genotyping methods for the replication studies are provided
in the SupplementaryMaterial. Since differences in LD patterns
between populations are known to affect the portability of
phenotypic associations when the replication effort is attempted
in populations that are distinct from the original population in
which the genome-wide study is performed (25), four cohorts
of Asian ancestry that were also a part of the IGGC were not
included in our replication analysis. Where more than one SNP
at a locus was genome-wide significant, i.e. in presence of LD,
only the single most associated SNP was chosen for replication.
A fixed-effect inverse variance meta-analysis of all the cohorts
was performed using the module ‘metan’ on Stata Statistical
Software, 11 (College Station, TX, USA).
Gene expression data for a subset of the TwinsUK cohort was
obtained from the MuTHER study (29). As a part of the
MuTHER study, 855 subjects from the TwinsUK cohort had
their transcript expression quantified in three different tissue
types (skin, fat and LCLs). This was done for 18 170 genes
across the genome using 27 499 probes on Illumina’s whole
genome expression array (HumanHT-12 version 3) further
details of the study methods are available in Nica et al. (29).
For the genome-wide significant SNPs in the TwinsUK cohort,
we tested for a possible eQTL effect on the overlapping gene.
SUPPLEMENTARYMATERIAL
Supplementary Material is available at HMG online.
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